Wolf Myles - Insider Non-Derivative Transactions at Akebia Therapeutics, Inc. (AKBA) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 6, 2024, Wolf Myles's relationship to Akebia Therapeutics, Inc. (AKBA) is Director, and currently has 97,681 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other AKBA insiders.
Data Source: SEC.
Wolf Myles - Insider Non-Derivative Transactions of AKBA Common Stock
Wolf Myles - Insider Non-Derivative Transactions at AKBA
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 7, 2024 | Acquisition -- (Common Stock) | 30000 | 0 | 97681 |
| Jun 7, 2023 | Acquisition -- (Common Stock) | 30000 | 0 | 67681 |